Healthpeak Properties stock trades below target as 2026 guidance firms up
Published on 08/31/2026 at 18:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Healthpeak Properties, Inc. (ISIN US42250P1030) stock is quoted around the low-$20 level as of August 31, 2026, with the shares still trading below the average analyst target despite stronger second-quarter results and tightened 2026 guidance for adjusted funds from operations per share.
Stock price and trading context
Recent market data show Healthpeak Properties stock changing hands around $20.78 on August 31, 2026, with the last closing price reported at $20.96, highlighting a modest pullback from the prior session while the broader year-to-date move remains positive.
On a five-day view the share price has eased by 0.86 percent, while since January 1, 2026 it is up 28.79 percent, illustrating how the recent dip comes after a strong multi-month recovery in the name.
Analyst data compiled in the same overview put the average 12-month price objective at $23.05, meaning the current $20.96 closing level sits 9.98 percent below that target and leaving scope for potential upside if the company delivers on its operating plan.
Latest earnings and guidance detail
Healthpeak Properties most recently reported second-quarter 2026 results, with revenue of $771.6 million for the period, above the $725.6 million that had been anticipated by the consensus, underscoring solid top-line momentum in its healthcare real estate portfolio.
The same summary indicates that management now anticipates adjusted funds from operations, framed as adjusted EPS, between $1.73 and $1.77 for fiscal 2026, a range that centers slightly above the earlier consensus estimate of $1.74 and reflects a more confident full-year outlook.
Sell-side models referenced in the data set project full-year 2026 earnings per share of $1.77, effectively aligning near the high end of the official $1.73 to $1.77 guidance band and signaling that analysts expect the company to meet or modestly beat its own outlook.
Analyst stance and market view
The same compilation of broker opinions assigns Healthpeak Properties an overall consensus rating of Hold, suggesting that many analysts see the shares as fairly valued on a risk-reward basis even though they still point to mid-single-digit percentage upside toward the $23.05 average target.
For investors, the combination of a 28.79 percent gain since the start of 2026 and only 9.98 percent remaining to the average objective implies that much of the recent fundamental improvement may already be reflected in the price, increasing the importance of future quarters living up to the $1.73 to $1.77 adjusted FFO guidance.
At the same time, the beat versus the second-quarter 2026 revenue consensus, with reported sales of $771.6 million compared with $725.6 million expected, highlights operational execution that could support valuations if Healthpeak maintains this performance in the second half of the year.
Core business and property focus
Healthpeak Properties, Inc. is a real estate investment trust focused on healthcare assets, including medical office buildings, life science campuses, and senior housing communities, generating rental income from leases with healthcare providers, research organizations, and operators across the sector.
The company typically structures long-term leases with creditworthy tenants in major metropolitan areas, aiming to deliver stable cash flows and support its adjusted funds from operations profile that underpins distributions to shareholders.
A representative asset within its portfolio is a modern life science campus that offers specialized laboratory and office space for biotech and pharmaceutical tenants, reflecting Healthpeak’s emphasis on properties where demand is supported by long-term trends in healthcare and research spending.
Stock level and investor takeaway
With Healthpeak Properties stock closing at $20.96 as of the latest completed trading session in August 2026, the shares remain listed on the New York Stock Exchange and trade in US dollars, giving US investors straightforward access to the healthcare REIT story through a liquid, large-cap vehicle.
Fact box
Company: Healthpeak Properties, Inc.
ISIN: US42250P1030
Ticker: DOC
Exchange: New York Stock Exchange
Price (as of August 31, 2026, 4:00 p.m. ET): $20.96 USD
Market cap: not specified in the available sources
Sector / Industry: Real estate investment trust - healthcare
Index membership: S&P 500
